EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting Circular RNAs (circRNAs) in Atherosclerosis Using CRISPR Technology

Areej Nazarudeen, V A Aswathy, Arun A Rauf, U V Aswathy, V R Mahesh Chandran, N Abhirami, S Sudhina, Akash Chandran, Janeesh Plakkal Ayyappan iD

The Journal of Gene Medicine · 2025

DOI: 10.1002/jgm.70048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Gene Medicine, 2025. Verfasst von Areej Nazarudeen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India. Hauptthemen laut MEDLINE: RNA, Circular, Atherosclerosis, CRISPR-Cas Systems. Die Arbeit nennt 144 Literaturangaben. Gefördert von: University of Kerala, Start-up Research Grant from the Science and Engineering Research Board (SERB), India, Start-up grant for new faculty from the University Grants Commission (UGC), India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory condition that remains a major global cause of cardiovascular morbidity and death. Circular RNAs (circRNAs), emerging as key regulators of biological processes, have been linked to atherosclerosis because of their functions in inflammation, lipid metabolism, and plaque stability. This review explores the biogenesis and cellular functions of circRNAs, highlighting specific circRNAs, such as circANRIL, circHIPK, and circRSF1, which influence atherosclerosis progressions and development. CRISPR‐Cas technology, specifically Cas9 and Cas13, has transformed the way atherosclerosis is studied and potentially treated. Targeting PCSK9, LDLR, and APOB to modify lipid metabolism, including lowering LDL cholesterol and repairing mutations in familial hypercholesterolemia, has been made possible using CRISPR‐Cas9 in atherosclerosis models. In parallel, CRISPR‐Cas13 offers a novel approach for RNA‐level intervention by selectively editing circRNAs, providing a dynamic approach to regulate atherosclerosis‐related pathways. In order to convert these findings into therapeutic treatments, future research should focus on elucidating the mechanics of circRNA, which in turn determines CRISPR‐Cas13, and designing specific delivery systems. This review paper demonstrates the revolutionary promise of circRNA research and CRISPR innovation in the treatment of atherosclerosis and underscores the need for extensive preclinical validation to bridge the gap towards clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularAtherosclerosisCRISPR-Cas SystemsHumansAnimalsGene EditingGenetic TherapyLipid Metabolism

Stichwörter der Autor:innen

CRISPR‐Cas13CRISPR‐Cas9atherosclerosiscircular RNAsinflammationlowering LDL cholesteroltargeting

Substanzen

RNA, Circular

Autor:innen und Institutionen

  • Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.
  • Department of Anatomy, P K Das Institute of Medical Sciences, Palakkad, Kerala, India.
  • Department of Biotechnology, University of Kerala, Thiruvananthapuram, Kerala, India.
  • DBT-SAHAJ National Facility for Mass Spectrometry, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India.
  • Centre for Advanced Cancer Research, Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.
  • Department of Nanoscience and Nanotechnology, University of Kerala, Thiruvananthapuram, Kerala, India.

ORCID-Profile: Janeesh Plakkal Ayyappan

Förderung

  • University of Kerala
  • Start-up Research Grant from the Science and Engineering Research Board (SERB), India
  • Start-up grant for new faculty from the University Grants Commission (UGC), India
  • University of Kerala research support in the form of Plan and Nonplan funds
  • Science and Engineering Research Board

Zitieren

APA

Nazarudeen, A., Aswathy, V. A., Rauf, A. A., Aswathy, U. V., Mahesh Chandran, V. R., Abhirami, N., Sudhina, S., Chandran, A., & Ayyappan, J. P. (2025). Targeting Circular RNAs (circRNAs) in Atherosclerosis Using CRISPR Technology. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70048

Vancouver

Nazarudeen A, Aswathy VA, Rauf AA, Aswathy UV, Mahesh Chandran VR, Abhirami N, et al. Targeting Circular RNAs (circRNAs) in Atherosclerosis Using CRISPR Technology. The Journal of Gene Medicine. 2025. doi:10.1002/jgm.70048

BibTeX
@article{Nazarudeen2025,
  author = {Nazarudeen, Areej and Aswathy, V A and Rauf, Arun A and Aswathy, U V and Mahesh Chandran, V R and Abhirami, N and Sudhina, S and Chandran, Akash and Ayyappan, Janeesh Plakkal},
  title = {Targeting Circular RNAs (circRNAs) in Atherosclerosis Using CRISPR Technology},
  journal = {The Journal of Gene Medicine},
  year = {2025},
  doi = {10.1002/jgm.70048}
}
Kostenlos starten →